Add to ORKGKey Words. Acute myelogenous leukemia • Cytogenetic abnormalities • Bone marrow transplantation Hematopoietic stem cell transplantation • Transplantation conditioning • Biological therapy Disclosure: No potential conflicts of interest were reported by the authors, planners, reviewers, or staff managers of this article
Acute myeloid leukemia (AML) has been well character-ized as a heterogeneous disorder of normal hema...
Therapy-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) is an increasingly recog...
Individual disclosures of potential conflicts of interest for the NCCN Acute Myeloid Leukemia Panel ...
2. Dufour A, Schneider F, Metzeler KH, et al: Acute myeloid leukemia with biallelic CEBPA gene mutat...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
: Acute myeloid leukemia (AML) is a clonal disorder resulting from acquired somatic mutations in hem...
Mixed phenotype acute leukemia (MPAL) encompasses a heterogeneous group of rare leukemias in which a...
Section editor George P. Canellos has disclosed no financial relationships relevant to the content o...
Letters to the Editor Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hyp...
Understanding and overcoming resistance to chemotherapy in acute myeloid leukemia For many years, cl...
Acute myeloid leukemia (AML) is a heterogeneous condition characterized by clonal proliferation of m...
Conflict-of-interest disclosure: The authors declare no competing financial interes
stantial progress in the treatment of acute myelogenous leukemia (AML). In this review we critically...
Section editor George P. Canellos has disclosed no financial relationships relevant to the content o...
Acute myeloid leukemia (AML) has been well character-ized as a heterogeneous disorder of normal hema...
Therapy-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) is an increasingly recog...
Individual disclosures of potential conflicts of interest for the NCCN Acute Myeloid Leukemia Panel ...
2. Dufour A, Schneider F, Metzeler KH, et al: Acute myeloid leukemia with biallelic CEBPA gene mutat...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
The content of this article has been reviewed by independent peer reviewers to ensure that it is bal...
: Acute myeloid leukemia (AML) is a clonal disorder resulting from acquired somatic mutations in hem...
Mixed phenotype acute leukemia (MPAL) encompasses a heterogeneous group of rare leukemias in which a...
Section editor George P. Canellos has disclosed no financial relationships relevant to the content o...
Letters to the Editor Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hyp...
Understanding and overcoming resistance to chemotherapy in acute myeloid leukemia For many years, cl...
Acute myeloid leukemia (AML) is a heterogeneous condition characterized by clonal proliferation of m...
Conflict-of-interest disclosure: The authors declare no competing financial interes
stantial progress in the treatment of acute myelogenous leukemia (AML). In this review we critically...
Section editor George P. Canellos has disclosed no financial relationships relevant to the content o...
Acute myeloid leukemia (AML) has been well character-ized as a heterogeneous disorder of normal hema...
Therapy-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/AML) is an increasingly recog...
Individual disclosures of potential conflicts of interest for the NCCN Acute Myeloid Leukemia Panel ...